Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01112449 · ClinicalTrials.gov registry record · NA

Influence of Selenium on Prostate Cancer Related Biomarkers

A NA study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
130
Enrollment target

NCT01112449: Completed NA study, sponsored by Milton S. Hershey Medical Center.

NCT01112449 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 130 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01112449, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target

Study Summary

Penn State Milton S. Hershey Medical Center researchers are trying to compare the effects of two different forms of selenium (selenium yeast and selenomethionine) on blood selenium levels and biomarkers of oxidative stress as primary endpoints. One in six men are at risk of getting prostate cancer in their lifetime. Participants will be asked to take over-the-counter selenium yeast supplements and selenomethionine or a placebo for nine out of twelve months.

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT selenomethionine
  • DIETARY_SUPPLEMENT low dose selenized-yeast
  • DIETARY_SUPPLEMENT high dose selenized-yeast

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2008-05
Est. Completion 2014-05
Phase NA
Milton S. Hershey Medical Center

396 total trials

What the finished NCT01112449 record still lists

NCT01112449 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.

NCT01112449 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01112449 about?

NCT01112449 is a clinical study titled "Influence of Selenium on Prostate Cancer Related Biomarkers". Penn State Milton S. Hershey Medical Center researchers are trying to compare the effects of two different forms of selenium (selenium yeast and selenomethionine) on blood selenium levels and biomarkers of oxidative stress as primary endpoints. One in six men are at risk of getting prostate cancer i...

What is the current status of trial NCT01112449?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2008-05. Estimated completion is 2014-05.

What interventions are being tested in trial NCT01112449?

The interventions under investigation include: Placebo (OTHER), selenomethionine (DIETARY_SUPPLEMENT), low dose selenized-yeast (DIETARY_SUPPLEMENT), high dose selenized-yeast (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01112449?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01112449's enrollment target sits among peer trials

130 733rd of 2000 higher than 1,257 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492036 · 130 participants

    Long-Term Follow-Up of Recipient of Gene Transfer Research

  • NCT01631617 · 130 participants · Phase 2

    Effects of Treatments on Atopic Dermatitis

  • NCT02368041 · 130 participants

    Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure

  • NCT02604277 · 130 participants · NA

    Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01112449, the US trial registry maintained by the National Library of Medicine. NCT01112449 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.